The WHO, WHY, WHAT, WHEN, WHERE, and HOW of clinical trial registriesMELDRUM, David R; DECHERNEY, Alan H.Fertility and sterility. 2011, Vol 96, Num 1, pp 2-5, issn 0015-0282, 4 p.Article

Difficulties in recruiting older people in clinical trials: An examination of barriers and solutionsRIDDA, I; MACINTYRE, C. R; LINDLEY, R. I et al.Vaccine. 2010, Vol 28, Num 4, pp 901-906, issn 0264-410X, 6 p.Article

RReACT goes global: Perils and pitfalls of constructing a global open-access database of registered analgesic clinical trials and trial resultsMUNCH, Troels; DUFKA, Faustine L; GREENE, Kaitlin et al.Pain (Amsterdam). 2014, Vol 155, Num 7, pp 1313-1317, issn 0304-3959, 5 p.Article

Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verifiedSEREBRUANY, Victor L.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 752-759, issn 0340-6245, 8 p.Article

Planning of clinical trialsBOISSEL, J.-P.Journal of internal medicine. 2004, Vol 255, Num 4, pp 427-438, issn 0954-6820, 12 p.Article

Cardiology clinical trial participation in community-based healthcare systems : Obstacles and opportunitiesSOMKIN, Carol P; ALTSCHULER, Andrea; GO, Alan S et al.Contemporary clinical trials. 2008, Vol 29, Num 5, pp 646-653, issn 1551-7144, 8 p.Article

Quality improvement methods as applied to a multicenter effectiveness trial: STAR*DWARDEN, Diane; RUSH, A. John; TRIVEDI, Madhukar et al.Contemporary clinical trials. 2005, Vol 26, Num 1, pp 95-112, issn 1551-7144, 18 p.Article

The expanding vaccine development pipeline, 1995―2008DAVIS, Matthew M; BUTCHART, Amy T; COLEMAN, Margaret S et al.Vaccine. 2010, Vol 28, Num 5, pp 1353-1356, issn 0264-410X, 4 p.Article

Why Has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?KHAN, Arif; BHAT, Amritha; KOLTS, Russell et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 4, pp 217-226, issn 1755-5930, 10 p.Article

Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countriesKISSER, Agnes; HEININGER, Ulrich; MOORTHY, Vasee S et al.Vaccine. 2011, Vol 29, Num 24, pp 4173-4174, issn 0264-410X, 2 p.Article

Real world TB vaccines : clinical trials in TB-endemic regionsMARK DOHERTY, T.Vaccine. 2005, Vol 23, Num 17-18, pp 2109-2114, issn 0264-410X, 6 p.Conference Paper

Template protocol for clinical trials investigating vaccines—Focus on safety elementsBONHOEFFER, Jan; IMOUKHUEDE, Egeruan B; HOSSAIN, Shah et al.Vaccine. 2013, Vol 31, Num 47, pp 5602-5620, issn 0264-410X, 19 p.Article

Assessment of blinding in clinical trialsHEEJUNG BANG; LIYUN NI; DAVIS, Clarence E et al.Controlled clinical trials. 2004, Vol 25, Num 2, pp 143-156, issn 0197-2456, 14 p.Article

The effect of scientific misconduct on the results of clinical trials : A delphi surveyAL-MARZOUKI, Sanaa; ROBERTS, Ian; MARSHALL, Tom et al.Contemporary clinical trials. 2005, Vol 26, Num 3, pp 331-337, issn 1551-7144, 7 p.Article

Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000)ODDONE, Eugene Z; OLSEN, Maren K; LINDQUIST, Jennifer Hoff et al.Controlled clinical trials. 2004, Vol 25, Num 4, pp 378-387, issn 0197-2456, 10 p.Article

A pragmatic-explanatory continuum indicator summary (PRECIS) : a tool to help trial designers : Making randomized trials more useful: the pragmatic attitude to RCT designTHORPE, Kevin E; ZWARENSTEIN, Merrick; CHALKIDOU, Kalipso et al.Journal of clinical epidemiology. 2009, Vol 62, Num 5, pp 464-475, issn 0895-4356, 12 p.Article

OMERACT : An international initiative to improve outcome measurement in rheumatologyBOERS, M; BROOKS, P; SIMON, L. S et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S10-S13, issn 0392-856X, SUP39Article

Negative trials in nephrology : what can we learn?NOVAK, James E; INRIG, Jula K; PATEL, Uptal D et al.Kidney international. 2008, Vol 74, Num 9, pp 1121-1127, issn 0085-2538, 7 p.Article

THE UNDER-REPRESENTATION OF OLDER PEOPLE IN CLINICAL TRIALS : BARRIERS AND POTENTIAL SOLUTIONSHABICHT, D. W; WITHAM, M. D; MCMURDO, M. E. T et al.The Journal of nutrition, health & aging. 2008, Vol 12, Num 3, pp 194-196, issn 1279-7707, 3 p.Article

Regulatory oversight of clinical trials in Africa: Progress over the past 5 yearsMAÏGA, Diadié; DICKY AKANMORI, Bartholomew; CHOCARRO, Liliana et al.Vaccine. 2009, Vol 27, Num 52, pp 7249-7252, issn 0264-410X, 4 p.Article

A likelihood approach to analyzing clinical trial data when treatments favor different outcomesAIN MCCLURE, Leslie; BROWN, Morton B.Contemporary clinical trials. 2006, Vol 27, Num 4, pp 340-352, issn 1551-7144, 13 p.Article

Ethical issues in Innovative Colorectal SurgeryMARRON, Jonathan M; SIEGLER, Mark.Diseases of the colon & rectum. 2005, Vol 48, Num 6, pp 1109-1113, issn 0012-3706, 5 p.Conference Paper

FDA guidance on prophylactic DNA vaccines: Analysis and recommendationsKLINMAN, Dennis M; KLASCHIK, Sven; TROSS, Debra et al.Vaccine. 2010, Vol 28, Num 16, pp 2801-2805, issn 0264-410X, 5 p.Article

Angiogenesis inhibitors in clinical development; where are we now and where are we going?ESKENS, Falm.British journal of cancer. 2004, Vol 90, Num 1, pp 1-7, issn 0007-0920, 7 p.Article

Empirical evaluation of the need for 'on-going consent' in clinical researchSMITH, William; GRADY, Christine; KROHMAL, Benjamin et al.AIDS (London). 2011, Vol 25, Num 1, pp 107-114, issn 0269-9370, 8 p.Article